Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bomedemstat + Momelotinib in Myelofibrosis
NCT07424950Phase 2Not yet recruiting
- Sponsor
- United Lincolnshire Teaching Hospitals NHS Trust
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of bomedemstat in myelofibrosis (MF), sponsored by United Lincolnshire Teaching Hospitals NHS Trust. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
bomedemstat
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT07424950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424950.